Literature DB >> 18445776

Amelioration of cisplatin-induced nephrotoxicity in rats by tetramethylpyrazine, a major constituent of the Chinese herb Ligusticum wallichi.

B H Ali1, M Al-Moundhri, M Tag Eldin, A Nemmar, S Al-Siyabi, K Annamalai.   

Abstract

Nephrotoxicity of the anticancer drug, cisplatin (CP) involves enhanced renal generation of reactive oxygen metabolites and lipid peroxidation caused by decreased levels of antioxidants and antioxidant enzymes. Tetramethylpyrazine (TMP) is known to act as a strong antioxidant. Therefore, in the present work, we aimed at testing the possible protective or palliative effect of TMP on CP nephrotoxicity in rats. TMP was given orally at a dose of 80 mg . kg(- 1) . day(- 1) for 7 days. Some of these rats were given a single intraperitoneal injection of CP (or vehicle) at a dose of 6 mg/kg on Day 6 of treatment. Animals were sacrificed 6 days after CP (or vehicle) treatment, and blood, urine, and kidneys were obtained. Nephrotoxicity was assessed biochemically by measuring creatinine and urea in serum, reduced glutathione (GSH) concentration in renal cortex, by urinalysis, and histopathologically by light microscopy. CP significantly increased the concentration of urea and creatinine (P < 0.05) by about 128% and 170%, respectively; increased urine volume and N-acetyl-beta-D-glucosaminidase (NAG) activity; and significantly decreased osmolality and protein concentrations. CP treatment reduced GSH by about 34% (P < 0.05) and superoxide dismutase (SOD) and total antioxidant activity (TOX) by about 28% and 21%, respectively (P < 0.05). TMP pretreatment significantly mitigated all of these effects. Sections from saline- and TMP-treated rats showed apparently normal proximal tubules. However, kidneys of CP-treated rats had a moderate degree of necrosis. This was markedly reduced when CP was given after pretreatment with TMP. CP cortical concentration was not significantly altered by TMP treatment. The results suggest that TMP ameliorated the histological, physiological, and biochemical indices of nephrotoxicity in rats. Pending further pharmacological and toxicological studies, TMP may potentially be useful as a nephroprotective agent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445776     DOI: 10.3181/0711-RM-315

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  12 in total

1.  Ameliorative effect of flunarizine in cisplatin-induced acute renal failure via mitochondrial permeability transition pore inactivation in rats.

Authors:  Arunachalam Muthuraman; Shailja Sood; Sumeet Kumar Singla; Ajay Rana; Atinderjeet Singh; Amandeep Singh; Jai Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-31       Impact factor: 3.000

2.  The effect of thymoquinone treatment on the combined renal and pulmonary toxicity of cisplatin and diesel exhaust particles.

Authors:  Badreldin H Ali; Mohammed Al Za'abi; Asem Shalaby; Priyadarsini Manoj; Mostafa I Waly; Javed Yasin; Mohamed Fahim; Abderrahim Nemmar
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-28

3.  Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoid saponin of Terminalia arjuna.

Authors:  Iman O Sherif
Journal:  Clin Exp Nephrol       Date:  2014-11-12       Impact factor: 2.801

4.  Mitochondrial dependent apoptosis: ameliorative effect of flunarizine on ischemia-reperfusion of celiac artery-induced gastric lesions in the rat.

Authors:  Arunachalam Muthuraman; Muthusamy Ramesh; Ashish Chauhan
Journal:  Dig Dis Sci       Date:  2011-02-16       Impact factor: 3.199

5.  Ligustrazine reverts anthracycline chemotherapy resistance of human breast cancer by inhibiting JAK2/STAT3 signaling and decreasing fibrinogen gamma chain (FGG) expression.

Authors:  Yu-Lin Liu; Ze-Xuan Yan; Yu Xia; Xiao-Ye Xie; Kai Zhou; Li-Li Xu; Yan-Long Shi; Qiang Wang; Jing-Wang Bi
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

6.  Ameliorative effect of sesamin in cisplatin-induced nephrotoxicity in rats by suppressing inflammation, oxidative/nitrosative stress, and cellular damage.

Authors:  B H Ali; S Al Salam; Y Al Suleimani; M Al Za'abi; M Ashique; P Manoj; M Sudhadevi; M Al Tobi; A Nemmar
Journal:  Physiol Res       Date:  2019-12-19       Impact factor: 1.881

7.  Tetramethylpyrazine potentiates arsenic trioxide activity against HL-60 cell lines.

Authors:  Yuni Wu; Youhua Xu; Yali Shen; Cuicui Wang; Gaili Guo; Tiantian Hu
Journal:  Braz J Med Biol Res       Date:  2012-02-16       Impact factor: 2.590

8.  Ligustrazine Attenuates Myocardial Injury Induced by Coronary Microembolization in Rats by Activating the PI3K/Akt Pathway.

Authors:  Qiang Su; Xiangwei Lv; Ziliang Ye
Journal:  Oxid Med Cell Longev       Date:  2019-05-02       Impact factor: 6.543

Review 9.  Mechanisms and Clinical Application of Tetramethylpyrazine (an Interesting Natural Compound Isolated from Ligusticum Wallichii): Current Status and Perspective.

Authors:  Yingke Zhao; Yue Liu; Keji Chen
Journal:  Oxid Med Cell Longev       Date:  2016-09-07       Impact factor: 6.543

Review 10.  Application of Herbal Traditional Chinese Medicine in the Treatment of Acute Kidney Injury.

Authors:  Hai-Di Li; Xiao-Ming Meng; Cheng Huang; Lei Zhang; Xiong-Wen Lv; Jun Li
Journal:  Front Pharmacol       Date:  2019-04-18       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.